DCF — SUMMIT MEDICAL CENTER
Enterprise Value: $189.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$189.9M
Enterprise Value
$48.3M
PV of Cash Flows
$141.6M
PV of Terminal Value
$228.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $307.0M | $26.1M | 8.0% | $8.5M | $7.7M |
| Year 2 | $316.2M | $30.0M | 9.0% | $11.1M | $9.2M |
| Year 3 | $325.7M | $34.2M | 10.0% | $13.9M | $10.4M |
| Year 4 | $335.4M | $36.9M | 11.0% | $15.6M | $10.6M |
| Year 5 | $345.5M | $38.9M | 11.0% | $16.7M | $10.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $189.9M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$298.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999879210111
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5